Kymera Therapeutics, Inc. (KYMR)

Insiders sold $81.2M in the past 12 months, 96% under disclosed plans; their starting stakes can't be measured from the filings. Why

Latest filing: Filed Oct 1 for a sale on Oct 1. Nello Mainolfi sold 30K shares ($3.4M) under a disclosed plan. Filing